Abstract
The new 2022 guidelines on the management of heart failure (HF) have been recently published1 replacing those from 2013 and 2017. These guidelines reflect a collaboration between the American Heart Association (AHA), the American College of Cardiology (ACC), and the Heart Failure Society of America (HFSA), incorporating many recent studies, providing updated definitions and novel patient-centric and evidence-based recommendations on the management of HF.
Funding Information
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R01-HL159062, R01-HL146691, T32-HL144456)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK123259, R01-DK033823)
  • Diabetes Action Research and Education Foundation
  • Monique Weill-Caulier Trust
  • Irma T. Hirschl Trust